-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Oramed Pharmaceuticals Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q4 2010 to Q1 2025.
- Oramed Pharmaceuticals Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$3.52M, a 138% decline year-over-year.
- Oramed Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$8.41M, a 18.3% increase from 2023.
- Oramed Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$10.3M, a 63.1% increase from 2022.
- Oramed Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$27.9M, a 31.8% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)